227 related articles for article (PubMed ID: 23365134)
1. TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.
Shinojima N; Hossain A; Takezaki T; Fueyo J; Gumin J; Gao F; Nwajei F; Marini FC; Andreeff M; Kuratsu J; Lang FF
Cancer Res; 2013 Apr; 73(7):2333-44. PubMed ID: 23365134
[TBL] [Abstract][Full Text] [Related]
2. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts.
Wildburger NC; Wood PL; Gumin J; Lichti CF; Emmett MR; Lang FF; Nilsson CL
J Proteome Res; 2015 Jun; 14(6):2511-9. PubMed ID: 25880480
[TBL] [Abstract][Full Text] [Related]
3. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF
J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
[TBL] [Abstract][Full Text] [Related]
8. Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.
Srinivasan VM; Gumin J; Camstra KM; Chen SR; Johnson JN; Shimizu Y; Parker Kerrigan BC; Shpall EJ; Lang FF; Kan P
J Neurosurg; 2019 Sep; 133(4):1182-1190. PubMed ID: 31491769
[TBL] [Abstract][Full Text] [Related]
9. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
Egea V; von Baumgarten L; Schichor C; Berninger B; Popp T; Neth P; Goldbrunner R; Kienast Y; Winkler F; Jochum M; Ries C
Cell Death Differ; 2011 May; 18(5):853-63. PubMed ID: 21127499
[TBL] [Abstract][Full Text] [Related]
10. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
[TBL] [Abstract][Full Text] [Related]
11. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
Yong RL; Shinojima N; Fueyo J; Gumin J; Vecil GG; Marini FC; Bogler O; Andreeff M; Lang FF
Cancer Res; 2009 Dec; 69(23):8932-40. PubMed ID: 19920199
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
14. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.
Liang H; Wang Q; Wang D; Zheng H; Kalvakolanu DV; Lu H; Wen N; Chen X; Xu L; Ren J; Guo B; Zhang L
Biochem Pharmacol; 2020 Oct; 180():114118. PubMed ID: 32585142
[TBL] [Abstract][Full Text] [Related]
15. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
[TBL] [Abstract][Full Text] [Related]
16. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
Tsuda H; Wada T; Yamashita T; Hamada H
J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.
Balyasnikova IV; Ferguson SD; Sengupta S; Han Y; Lesniak MS
PLoS One; 2010 Mar; 5(3):e9750. PubMed ID: 20305783
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
Kurogi R; Nakamizo A; Suzuki SO; Mizoguchi M; Yoshimoto K; Amano T; Amemiya T; Takagishi S; Iihara K
J Neurosurg; 2018 Mar; 130(1):44-55. PubMed ID: 29521593
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells expressing BMP2 suppress glioma stem cell growth and stemness through Bcl-2/Bax signaling.
Feng J; Yao Z; Yang H; Ma J; Zhong X; Qin Y; Li J
J Cancer Res Ther; 2022 Dec; 18(7):2033-2040. PubMed ID: 36647967
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.
Lee HK; Finniss S; Cazacu S; Bucris E; Ziv-Av A; Xiang C; Bobbitt K; Rempel SA; Hasselbach L; Mikkelsen T; Slavin S; Brodie C
Oncotarget; 2013 Feb; 4(2):346-61. PubMed ID: 23548312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
